ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕

2021

  • Home
  • 2021
June 24, 2021
Mary Lou Smith, JD at podium
June 24, 2021
Categories
  • Editorials

Advocacy and the NCI’s National Clinical Trials Network

Advocates play an important role in each of the NCTN groups, helping to inform the design and implementation of clinical trials
Do you like it?
0 Read more
June 24, 2021
Green tea extract pills
June 24, 2021
Categories
  • New Trials

Now Enrolling: Clinical trial EA8184 is exploring if green tea extract pills can help reduce the progression of prostate cancer

This study will evaluate the effects and safety of green tea catechins in men on active surveillance for prostate cancer
Do you like it?
1 Read more
June 24, 2021
MATCH image
June 24, 2021
Categories
  • Editorials

Ongoing Trial: For patients with advanced or rare cancers, NCI-MATCH may offer a treatment option

Each arm of NCI-MATCH—and every patient who participates—provide valuable information on potential cancer treatments.
Do you like it?
0 Read more
June 24, 2021
Research dictionary entry
June 24, 2021
Categories
  • Trial Results

Trial Results: ECOG-ACRIN research round-up – Spring 2021

Summaries of recently reported ECOG-ACRIN research results
Do you like it?
0 Read more
Prev page
1234
Next page

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Tags

Acute lymphoblastic leukemia Adolescents and young adults Advocacy Bladder cancer Breast cancer Caregiving Communication De-escalation Head and neck cancer Health equity HER2+ breast cancer Immune system therapy Immunotherapy In memory Kidney cancer Leukemia Lung cancer Lymphoma Mammography Mantle cell lymphoma Melanoma Multiple myeloma Myeloma NCI-MATCH Nose and sinus cancer Pancreatic cancer Pancreatic cysts Patient care Personalized medicine Personalized screening Personalized treatment Precision medicine Prevention Prostate cancer Renal cell carcinoma Research results Sarcoma Screening Side effects Squamous cell carcinoma Surveillance Survivorship Symptom management Targeted therapy Throat cancer

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc